Deals Of The Week: Sanofi/Genfar, Janssen/Astellas, Evotec/Bayer
It was an important week for Celgene, which made two cancer deals while producing data that help validate its $2.9 billion buyout of Abraxane.
It was an important week for Celgene, which made two cancer deals while producing data that help validate its $2.9 billion buyout of Abraxane.